What is Treprostinil?

Category: Prescription Drugs

Most popular types: Remodulin Tyvaso

false

Treprostinil is a prostoglandin vasodilator. As an injectable, it is used in the treatment of pulmonary arterial hypertension (PAH).

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Idiopathic pulmonary arterial hypertension 7 3
Pulmonary hypertension 6 2
Congestive heart failure 2 1
Chest pain 1 0
Idiopathic pulmonary fibrosis 1 1
Shortness of breath (dyspnea) 1 1

  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 2
Moderate 0
Mild 3
None 0

Commonly reported side effects and conditions associated with Treprostinil

Side effect Patients Percentage
Jaw pain 3
Cough 2
Chronic fatigue 1
Constipation 1
Fatigue 1
Generalized weakness (asthenia) 1

Show all 14 reported side effects

Why patients stopped taking Treprostinil

Multiple reasons could be selected

Reason Patients Percentage
Did not seem to work 1
See 1 patient who's stopped taking Treprostinil

Duration

Currently taking Treprostinil

Duration Patients Percentage
5 - 10 years 1

Stopped taking Treprostinil

Duration Patients Percentage
1 - 2 years 1
Adherence
Adherence Evaluations Percentage
Always 5
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations Percentage
Very hard to take 1
Somewhat hard to take 1
A little hard to take 2
Not at all hard to take 1
Cost per month
Cost per month Evaluations Percentage
$200+ 1
$100-199 0
$50-99 0
$25-49 0
< $25 0
Not specified 4

What people switch to and from

Patients started taking Treprostinil after stopping:

Treatment Patients Percentage
Epoprostenol 1
Last updated:

1 patient evaluation for Treprostinil

Apr 11, 2018 (Started Dec 15, 2015)

  • Effectiveness
    Moderate (for pulmonary hypertension)
  • Side effects
    Severe (pain)
  • Adherence
    Always
  • Burden
    Very hard to take
Dosage: 5 mg Every other day

  • 0 helpful marks
Last updated:
Showing 1 of 1 patient evaluation for Treprostinil